SNES - セネステック （SenesTech Inc.） セネステックSNESのチャート
SNESの企業情報
| symbol | SNES |
|---|---|
| 会社名 | SenesTech Inc （セネステック） |
| 分野（sector） | Basic Industries 素材 |
| 産業（industry） | Agricultural Chemicals |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 原材料・素材（Materials） |
| 概要 | 事業概要 SenesTech Inc. is a United States-based biotechnology platform and research company. The Company is engaged in developing a technology for managing animal populations by fertility control. It offers ContraPest a fertility control product candidate. ContraPest's technology and approach targets the reproductive capabilities of both sexes. Using bait stations ContraPest is dispensed in a palatable liquid formulation that promotes sustained consumption by rodent communities. Its formulation causes both female and male rats to become infertile once they have consumed the dose. The active ingredient in females accelerates the rate at which ovarian follicles (egg structures) are depleted. Once these cells are gone the animal cannot reproduce. In males there is a marked reduction in the ability to fertilize eggs and often complete sterility. ContraPest is designed formulated and dispensed for handlers and non-target species such as wildlife and pets in a biodegradable product. セネステックは米国の動物関連医薬品企業。動物の出生コントロ―ルにより、害虫の個体数を管理する技術の開発に従事。同社パイプラインには、植物ベ―スで出生制限をする「コントラペスト」や動物向け健康食品、非外科スプレ―、動物向けがん治療薬などを開発する。本社所在地はアリゾナ州フラッグスタッフ。 SenesTech is changing the model for pest management by targeting one of the root causes of the problem: reproduction. ContraPest® is an innovative technology with an approach that targets the reproductive capabilities of both sexes in rat populations, inducing egg loss in female rats and impairing sperm development in males. Using a proprietary bait delivery method, ContraPest® is dispensed in a highly palatable liquid formulation that promotes sustained consumption by rat communities. ContraPest® is designed, formulated and dispensed to be low hazard for handlers and non-target species such as wildlife, livestock and pets, where the active ingredients break down rapidly. |
| 本社所在地 | 3140 N. Caden Court Suite 1 Flagstaff AZ 86004 USA |
| 代表者氏名 | Loretta Powers Mayer ロレッタパワーズメイヤー |
| 代表者役職名 | Chairman of the Board Chief Executive Officer Chief Scientific Officer |
| 電話番号 | +1 928-779-4143 |
| 設立年月日 | 38169 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | 2016年 |
| 従業員数 | － |
| url | www.senestech.com |
| nasdaq_url | https://www.nasdaq.com/symbol/snes |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -11.53600 |
| 終値（lastsale） | 0.765 |
| 時価総額（marketcap） | 17920344.555 |
| 時価総額 | 時価総額（百万ドル） 20.16449 |
| 売上高 | 売上高（百万ドル） 0.09000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 16.42749 |
| 当期純利益 | 当期純利益（百万ドル） -12.02600 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 SenesTech Inc revenues increased from $17K to $55K. Net loss decreased 4% to $6.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects General and administrative - Balanci decrease of 21% to $2.8M (expense) Other decrease of 25% to $391K (expense) Stock-based Compensation in R&D decrease of 68% to $58K (expense). |
SNESのテクニカル分析
SNESのニュース
Data-Based Analysis Of SenesTech Inc. (SNES) 2021/12/04 13:30:00 Stocks Register
SenesTech Inc. (NASDAQ:SNES) concluded the trading at $1.05 on Friday, December 03 with a fall of -6.25% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $1.12 and 5Y monthly beta was reading 1.58 with its price kept floating in the range Data-Based Analysis Of SenesTech Inc. (SNES) Read More »
Short Interest in SenesTech, Inc. (NASDAQ:SNES) Declines By 30.8% 2021/12/02 14:12:42 Dakota Financial News
SenesTech, Inc. (NASDAQ:SNES) was the recipient of a large drop in short interest during the month of November. As of November 15th, there was short interest totalling 218,700 shares, a drop of 30.8% from the October 31st total of 316,100 shares. Approximately 2.1% of the shares of the company are short sold. Based on an []
Renaissance Technologies LLC Invests $321,000 in SenesTech, Inc. (NASDAQ:SNES) 2021/11/26 09:36:45 Dakota Financial News
Renaissance Technologies LLC bought a new position in shares of SenesTech, Inc. (NASDAQ:SNES) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 199,450 shares of the companys stock, valued at approximately $321,000. Renaissance Technologies LLC owned approximately 1.64% of SenesTech as of its most recent []
SenesTech (NASDAQ:SNES) Posts Quarterly Earnings Results, Meets Estimates 2021/11/13 05:50:41 Dakota Financial News
SenesTech (NASDAQ:SNES) announced its earnings results on Wednesday. The company reported ($0.18) earnings per share for the quarter, meeting the consensus estimate of ($0.18), MarketWatch Earnings reports. SenesTech had a negative net margin of 1,785.31% and a negative return on equity of 81.03%. During the same period in the prior year, the firm earned ($0.56) []
Short Interest in SenesTech, Inc. (NASDAQ:SNES) Declines By 30.8% 2021/12/02 14:12:42 Dakota Financial News
SenesTech, Inc. (NASDAQ:SNES) was the recipient of a large drop in short interest during the month of November. As of November 15th, there was short interest totalling 218,700 shares, a drop of 30.8% from the October 31st total of 316,100 shares. Approximately 2.1% of the shares of the company are short sold. Based on an []
Renaissance Technologies LLC Invests $321,000 in SenesTech, Inc. (NASDAQ:SNES) 2021/11/26 09:36:45 Dakota Financial News
Renaissance Technologies LLC bought a new position in shares of SenesTech, Inc. (NASDAQ:SNES) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 199,450 shares of the companys stock, valued at approximately $321,000. Renaissance Technologies LLC owned approximately 1.64% of SenesTech as of its most recent []
SenesTech (NASDAQ:SNES) Posts Quarterly Earnings Results, Meets Estimates 2021/11/13 05:50:41 Dakota Financial News
SenesTech (NASDAQ:SNES) announced its earnings results on Wednesday. The company reported ($0.18) earnings per share for the quarter, meeting the consensus estimate of ($0.18), MarketWatch Earnings reports. SenesTech had a negative net margin of 1,785.31% and a negative return on equity of 81.03%. During the same period in the prior year, the firm earned ($0.56) []
SenesTech, Inc. (NASDAQ:SNES) Short Interest Update 2021/11/04 09:50:41 Transcript Daily
SenesTech, Inc. (NASDAQ:SNES) was the target of a significant decrease in short interest in October. As of October 15th, there was short interest totalling 85,500 shares, a decrease of 15.9% from the September 30th total of 101,700 shares. Based on an average daily volume of 162,100 shares, the days-to-cover ratio is currently 0.5 days. Approximately []
SenesTech to Present at the Lytham Partners Fall 2021 Investor Conference 2021/09/30 20:15:00 PR Newswire
PHOENIX, Sept. 30, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will present at the Lytham Partners Fall 2021 Investor Conference on Thursday, October 7,
SenesTech, Huaneng Power lead energy/material gainers; Cypress Environmental, Intrepid Potash among major losers 2021/08/19 18:00:18 Seeking Alpha
SenesTech Announces 2021 Second Quarter Financial and Operational Results 2021/08/12 20:05:00 PR Newswire
PHOENIX, Aug. 12, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the first and only EPA registered rat contraceptive, ContraPest®, announced today revenues for the second quarter